BP
IMMU

Banyan Partners’s Immunomedics Inc IMMU Stock Holding History

Banyan Partners’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$725K Hold
195,000
– – 0.06% 257
2014
Q2 		$712K Hold
195,000
– – 0.06% 274
2014
Q1 		$821K Hold
195,000
– – 0.07% 243
2013
Q4 		$897K Buy
195,000
+20,000
+11% +$89.1K 0.06% 242
2013
Q3 		$1.08M Hold
175,000
– – 0.1% 174
2013
Q2 		$952K Buy
+175,000
New +$575K 0.19% 111

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Banyan Partners's IMMU Position: Q3 2014 in Review

Banyan Partners held its Immunomedics Inc (IMMU) position steady in Q3 2014 at 195,000 shares worth $725K. The position accounts for 0.06% of the portfolio, ranked #257.

Banyan Partners first reported a position in IMMU in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.08M in Q3 2013. 81 funds tracked by Wall St. Rank hold IMMU as of Q3 2014.

  • Banyan Partners held 195,000 shares of Immunomedics Inc worth $725K as of Q3 2014.
  • Banyan Partners left its Immunomedics Inc share count unchanged in Q3 2014.
  • Immunomedics Inc made up 0.06% of Banyan Partners's portfolio in Q3 2014, its #257 holding.
  • Banyan Partners first reported a position in Immunomedics Inc in Q2 2013 and has held it in 6 quarters since.
  • Banyan Partners's Immunomedics Inc position peaked at $1.08M in Q3 2013.
  • 81 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.